January 11, 2022
January 11, 2022 – The U.S. FDA has announced revisions to the Johnson & Johnson (Janssen) COVID-19
vaccine fact sheets regarding the risk of immune thrombocytopenia (ITP)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Health Insurance
January 10, 2022
January 10, 2022 – Quviviq (daridorexant – Idorsia) has received FDA approval to treat adults who have insomnia characterized by difficulties with sleep onset and/or sleep
January 7, 2022
January 7, 2022 – Viona Pharmaceuticals has recalled 33 lots of Metformin Hydrochloride Extended-Release Tablets, USP 750mg, due to N-nitrosodimethylamine (NDMA) amounts
January 7, 2022
January 7, 2022 – The U.S. FDA has updated emergency use authorization for Moderna's COVID-19 vaccine
to shorten the time between the primary vaccination series and receipt
January 7, 2022
January 7, 2022 – Descovy® (emtricitabine/tenofovir alafenamide – Gilead) has been approved to treat HIV-1 infection in pediatric patients [weighing at least 14kg (31 pounds) and
January 4, 2022
January 4, 2022 – Par Pharmaceutical has launched the first generic version of Merz Pharmaceuticals’
Cuvposa® (glycopyrrolate) oral solution. Both Cuvposa and its generic are indicated
December 30, 2021
December 30, 2021 – The U.S. FDA has approved Recorlev® (levoketoconazole), manufactured by Xeris Biopharma, to treat endogenous hypercortisolemia in adults diagnosed
December 28, 2021
December 28, 2022 – Leo Pharma's AdbryTM (tralokinumab-ldrm) has received FDA approval to treat moderate to severe atopic dermatitis in adults whose disease is not adequately